Citrate-dextrose Solution (ACD)

<strong>Citrate-dextrose Solution (ACD)</strong>_x000D_ <strong>Catalog number:</strong> B2015129_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 50 mL_x000D_ <strong>Molecular Weight or Concentration:</strong> N/A_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> 2-8°C_x000D_ <strong>Keywords:</strong> Acid citrate-dextrose, Anticoagulant citrate-dextrose_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Wright S, Steinwandel U, Ferrari P. Citrate anticoagulation using ACD solution A during long-term haemodialysis Nephrology (Carlton). 2011 May;16(4):396-402._x000D_ 2: Bozorgmanesh R, Sutton-Burges JW, Tablin F. Comparison of equine platelet function and survival in whole blood collected in acid-citrate-dextrose solution or citrate-phosphate-dextrose-adenine solution Vet Clin Pathol. 2017 Jun;46(2):262-268._x000D_ 3: Flanigan MJ, Pillsbury L, Sadewasser G, Lim VS. Regional hemodialysis anticoagulation: hypertonic tri-sodium citrate or anticoagulant citrate dextrose-A Am J Kidney Dis. 1996 Apr;27(4):519-24._x000D_ 4: Nedelcu E, Ziman A, Fernando LP, Cook K, Bumerts P, Schiller G. Exclusive use of acid citrate dextrose for anticoagulation during extracorporeal photopheresis in patients with contraindications to heparin: an effective protocol J Clin Apher. 2008;23(2):66-73._x000D_ 5: DeSimone RA, Myers GD, Guest EM, Shi PA. Combined heparin/acid citrate dextrose solution A anticoagulation in the Optia continuous mononuclear cell protocol for pediatric lymphocyte apheresis J Clin Apher. 2019 Aug;34(4):487-489._x000D_ 6: Osby M, Barton P, Lam CN, Tran MH. Acid-citrate-dextrose Formula A versus heparin as primary catheter lock solutions for therapeutic apheresis Transfusion. 2014 Mar;54(3):735-43._x000D_ 7: Vandromme MJ, McGwin G Jr, Weinberg JA. Blood transfusion in the critically ill: does storage age matter? Scand J Trauma Resusc Emerg Med. 2009 Aug 13;17:35._x000D_ 8: Boszczowski I, Nóbrega de Almeida Júnior J, Peixoto de Miranda EJ, Pinheiro Freire M, Guimarães T, Chaves CE, Cais DP, Strabelli TM, Risek CF, Soares RE, Rossi F, Costa SF, Levin AS. Nosocomial outbreak of Pantoea agglomerans bacteraemia associated with contaminated anticoagulant citrate dextrose solution: new name, old bug? J Hosp Infect. 2012 Mar;80(3):255-8._x000D_ 9: Bray K, Lynde C, Vu T, Patterson A, Reich RR, Mason TM, Liu HD. Prevalence of baseline hypocalcemia and symptomatic hypocalcemia during leukapheresis J Clin Apher. 2023 Dec;38(6):654-663._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/327846">10: MacDonald R. Red cell 2,3-diphosphoglycerate and oxygen affinity Anaesthesia. 1977 Jun;32(6):544-53. </a>_x000D_ _x000D_ <strong>Products Related to Citrate-dextrose Solution (ACD) can be found at</strong> <a href="https://moleculardepot.com/product-category/Chemicals/"> Chemicals</a>